# Investigation of Drug-drug Interaction of HRS-5965 With Clopidogrel and Clarithromycin in Healthy Subjects

> **NCT07040787** · PHASE1 · COMPLETED · sponsor: **Chengdu Suncadia Medicine Co., Ltd.** · enrollment: 36 (actual)

## Conditions studied

- Complement Mediated Glomerular Diseases
- Hemolytic Anemia

## Interventions

- **DRUG:** HRS-5965 Capsules
- **DRUG:** Clopidogrel
- **DRUG:** Clarithromycin

## Key facts

- **NCT ID:** NCT07040787
- **Lead sponsor:** Chengdu Suncadia Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-08
- **Primary completion:** 2025-08-17
- **Final completion:** 2025-08-17
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2025-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07040787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07040787, "Investigation of Drug-drug Interaction of HRS-5965 With Clopidogrel and Clarithromycin in Healthy Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07040787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*